This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Society of Japanese Pharmacists | |
|---|---|
| Name | Society of Japanese Pharmacists |
| Native name | 日本薬剤師会 |
| Founded | 1880s |
| Headquarters | Tokyo |
| Members | pharmacists |
Society of Japanese Pharmacists is a professional association representing pharmacists in Japan, providing standards, education, advocacy, and research support. The organization engages with national institutions, regulatory bodies, universities, and international organizations to advance pharmaceutical practice and public health. It maintains relationships with professional societies, academic associations, hospitals, and industry groups to influence policy, curriculum, and clinical practice.
The association traces its origins to late 19th-century professional movements that coincided with the Meiji Restoration, engaging contemporaneously with institutions such as Ministry of Education, Culture, Sports, Science and Technology (Japan), Tokyo Imperial University, Osaka University, Kyoto University, Keio University, and Waseda University faculty who shaped modern pharmacy. During the Taishō period and Shōwa period the society interacted with entities including Tokyo Medical and Dental University, National Diet Library, Imperial Household Agency, Ministry of Health, Labour and Welfare (Japan), and regional prefectural associations. Postwar reconstruction saw collaboration with organizations like United Nations, World Health Organization, Allied Occupation of Japan, and Japan Pharmaceutical Manufacturers Association as the group helped standardize licensure and practice alongside courts such as the Supreme Court of Japan and legislative bodies including the National Diet of Japan. In recent decades the society has engaged with contemporary institutions like Japan Society for the Promotion of Science, Japan Medical Association, Japanese Red Cross Society, Japan External Trade Organization, Ministry of Economy, Trade and Industry (Japan), and international partners.
The society's governance connects with professional bodies such as Japan Pharmaceutical Association, Japan Primary Care Association, Japanese Society of Hospital Pharmacists, Japanese Society of Clinical Pharmacology and Therapeutics, Japanese Pharmacological Society, and academic departments at Hokkaido University, Tohoku University, Nagoya University, Kyushu University, and Kanazawa University. Membership includes pharmacists trained at institutions like Showa University, Nagasaki University, Shinshu University, and graduates of programs regulated by Ministry of Health, Labour and Welfare (Japan). Leadership often liaises with corporate stakeholders such as Takeda Pharmaceutical Company, Astellas Pharma, Eisai, Chugai Pharmaceutical, Otsuka Pharmaceutical, and regulatory consultancies linked to Japan External Trade Organization and prefectural health bureaus. Local chapters coordinate with municipal offices like Tokyo Metropolitan Government and prefectural governments including Osaka Prefecture, Kanagawa Prefecture, and Saitama Prefecture.
The society organizes continuing professional development programs, conferences, and symposia that bring together speakers from World Health Organization, United Nations Development Programme, International Pharmaceutical Federation, American Pharmacists Association, Royal Pharmaceutical Society, European Medicines Agency, Food and Drug Administration, and regional counterparts such as Korean Pharmaceutical Association and Chinese Pharmaceutical Association. Annual meetings feature contributions from university centers including Osaka University Hospital, Keio University Hospital, St. Marianna University School of Medicine Hospital, and research institutes like RIKEN, AIST, and National Institute of Health Sciences (Japan). Public health campaigns have coordinated with Japanese Red Cross Society, Japan Medical Association, and disaster-response agencies like Fire and Disaster Management Agency during events similar to responses to the 2011 Tōhoku earthquake and tsunami.
The society contributes to licensure frameworks established by Ministry of Health, Labour and Welfare (Japan) and curricular standards influenced by accreditation bodies and universities such as Tokyo Medical and Dental University, Kyoto Prefectural University of Medicine, and International University of Health and Welfare. It issues guidelines informed by clinical research from centers like National Cancer Center (Japan), National Center for Global Health and Medicine, and specialty groups including Japanese Society of Oncology Pharmacists and Japanese Society of Pharmaceutical Oncology. The society collaborates with continuing education providers and examination committees connected to Japan Pharmaceutical Association and academic consortia at Sophia University and Meiji University.
The society publishes journals, guidelines, and position papers drawing on work from researchers affiliated with University of Tokyo Hospital, Osaka University Graduate School of Medicine, Kyoto University Hospital, Kobe University, Hiroshima University, and laboratories at Nagasaki University School of Medicine. It disseminates research on pharmacotherapy, pharmacokinetics, pharmacoepidemiology, and pharmacovigilance in partnership with organizations such as Pharmaceuticals and Medical Devices Agency (Japan), Japan Society for Bioscience, Biotechnology, and Agrochemistry, Japanese Society of Clinical Oncology, and databases maintained by National Institute of Public Health (Japan). The society's publications reference clinical trials and regulatory submissions involving companies like Daiichi Sankyo, Sumitomo Pharma, Mitsubishi Tanabe Pharma, and guidelines developed with input from specialty societies including Japanese Society of Nephrology and Japanese Society of Cardiology.
The society advocates on issues tied to healthcare delivery, medication safety, and pharmaceutical regulation with stakeholders such as Ministry of Health, Labour and Welfare (Japan), the National Diet of Japan committees, and prefectural health authorities. It provides expert testimony and policy recommendations to entities including Pharmaceuticals and Medical Devices Agency (Japan), Japan Fair Trade Commission, and patient organizations like Japan Patients Association and collaborates with professional coalitions alongside Japan Medical Association and Japan Nursing Association. The society has engaged with legislative reforms concerning reimbursement and practice scope, interfacing with insurance administrators like Japan Health Insurance Association and public health initiatives promoted by Ministry of Economy, Trade and Industry (Japan).
Internationally, the society partners with bodies such as World Health Organization, International Pharmaceutical Federation, International Council of Nurses, European Medicines Agency, U.S. Food and Drug Administration, International Society of Pharmacovigilance, and regional groups like Asia Pacific Pharmaceutical Forum and ASEAN Pharmaceuticals Product Working Group. Academic exchanges occur with universities including Harvard Medical School, University of Oxford, University of Cambridge, Stanford University, Seoul National University, Peking University, University of Melbourne, Monash University, and collaborative research with institutes like NIH and European Molecular Biology Laboratory. Bilateral projects have involved pharmaceutical firms such as GlaxoSmithKline, Pfizer, Novartis, and Roche as well as multilateral programs administered by United Nations agencies and global health alliances.
Category:Pharmacy organizations in Japan